Patent · US Active

Metallo-beta-lactamase inhibitors

US9708336B2 · kind B2 · utility

4Cited by

6References

26Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Mihir Mandal · Westfield, US
Haifeng Tang · South San Francisco, US
Li Xiao · Cranbury, US
Jing Su · Scotch Plains, US
Guoqing Li · Montgomery, US
Shu-Wei Yang · Worcester, US
Weidong Pan · Somerville, US
Haiqun Tang · Montgomery, US
Reynalda K. DeJesus · East Brunswick Township, US
Jacqueline D. Hicks · Scotch Plains, US
Matthew Lombardo · Flemington, US
Hong Dong Chu · Livingston, US
William K. Hagmann · Westfield, US
Alex Pasternak · Princeton, US
Xin Gu · Scotch Plains, US
Jinlong Jiang · Scotch Plains, US
Shuzhi Dong · Plainsboro, US
Fa-Xiang Ding · Staten Island, US
Clare London · Chatham, US
Dipshikha Biswas · Woodbridge, US
Katherine Young · Metuchen, US
David N. Hunter · Hatfield, US
Zhiqiang Zhao · Scotch Plains, US
Dexi Yang · Livingston, US

Key dates

Filing date	Jan 16, 2015
Grant date	Jul 18, 2017
Priority date	—
Expiry date	Jan 16, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I) that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.